1. New Products

New Products

Cat. No. Product Name Target Research Area Added Chemical Structure
HY-101518 APG-115

MDM-2/p53

Cancer

2019-07 APG-115
HY-112301A cis-Pralsetinib

RET

Cancer

2019-07 cis-Pralsetinib
HY-128343 KDM4-IN-2

Histone Demethylase

Cancer

2019-07 KDM4-IN-2
HY-100864 mPGES1-IN-3

PGE synthase

Inflammation/Immunology

2019-07 mPGES1-IN-3
HY-107980 DS28120313

Others

Inflammation/Immunology

2019-07 DS28120313
HY-101116 GLP-1R Antagonist 1

Glucagon Receptor

Metabolic Disease

2019-07 GLP-1R Antagonist 1
HY-108706 KDM2A/7A-IN-1

Histone Demethylase

Cancer

2019-07 KDM2A/7A-IN-1
HY-101114 LAS191954

PI3K

Inflammation/Immunology

2019-07 LAS191954
HY-101281 VU 6008667

Others

Neurological Disease

2019-07 VU 6008667
HY-P0162 HCV-IN-4

HCV; HCV Protease

Infection

2019-07 HCV-IN-4
HY-101508 GNA002

Histone Methyltransferase

Cancer

2019-07 GNA002
HY-P0178 LXW7

Integrin

Cardiovascular Disease

2019-07 LXW7
HY-101511 TTT-28

Others

Cancer

2019-07 TTT-28
HY-128353 ROR agonist-1

ROR

Inflammation/Immunology

2019-07 ROR agonist-1
HY-128710 2'-Fluorothymidine

Others

Others

2019-07 2'-Fluorothymidine
HY-B2209B Hydroxocobalamin acetate

Others

Metabolic Disease

2019-07 Hydroxocobalamin acetate
HY-16926 CK-666

Arp2/3 Complex

Others

2019-07 CK-666
HY-101437 Ralfinamide

Sodium Channel

Neurological Disease

2019-07 Ralfinamide
HY-101437A Ralfinamide mesylate

Sodium Channel

Neurological Disease

2019-07 Ralfinamide mesylate
HY-108359 Alsterpaullone

CDK; GSK-3

Cancer

2019-07 Alsterpaullone